Fig. 3From: In vivo enhancement of the MAGE-specific cellular immune response by a recombinant MAGE1-MAGE3-TBHSP70 tumor vaccineT cell sub-population profile of mice before and after recombinant protein vaccination. a CD3+ T cells, b CD4+ T cells, c CD8+ T cells and d CD20+ cellsBack to article page